BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SLC34A2, ENSG00000157765, O95436, NPTIIb, NAPI-IIb, NAPI-3B, FLJ90534, 10568
7 results:

  • 1. Rectal neuroendocrine tumors in a colon cancer screening colonoscopy program. Sixteen-year single institution experience.
    Dąbkowski K; Michalska K; Rusiniak-Rosińska N; Urasińska E; Bielicki D; Starzyńska T
    Scand J Gastroenterol; 2023 Mar; 58(3):310-313. PubMed ID: 36121191
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. slc34a2 promotes cancer proliferation and cell cycle progression by targeting TMPRSS3 in colorectal cancer.
    Yang Y; Wu J; Yu X; Wu Q; Cao H; Dai X; Chen H
    Pathol Res Pract; 2022 Jan; 229():153706. PubMed ID: 34929599
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The slc34a2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer.
    Li X; Xing J; Wang H; Yu E
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30038060
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer.
    Liu L; Yang Y; Zhou X; Yan X; Wu Z
    Biomed Pharmacother; 2018 Mar; 99():645-654. PubMed ID: 29653487
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
    Roskoski R
    Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.
    Aisner DL; Nguyen TT; Paskulin DD; Le AT; Haney J; Schulte N; Chionh F; Hardingham J; Mariadason J; Tebbutt N; Doebele RC; Weickhardt AJ; Varella-Garcia M
    Mol Cancer Res; 2014 Jan; 12(1):111-8. PubMed ID: 24296758
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of ROS1 rearrangement in gastric adenocarcinoma.
    Lee J; Lee SE; Kang SY; Do IG; Lee S; Ha SY; Cho J; Kang WK; Jang J; Ou SH; Kim KM
    Cancer; 2013 May; 119(9):1627-35. PubMed ID: 23400546
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.